CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to IPN.PA

Nanoliposomal Irinotecan

Phase 2
Ipsen S.A. (IPN.PA)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Aug '27
IPN.PAPhase 2

Nanoliposomal irinotecan Phase 2 Est. Readout

Nanoliposomal Irinotecan
Aug 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Advanced Biliary Tract Cancer

View Full Landscape
Drug Information

Target Indication

Advanced Biliary Tract Cancer

Clinical Trial

NCT04005339

Last updated: 8/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.